Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases
For people with type 2 diabetes or obesity, synthetic versions of this hormone have been life-changing
Klin.Wochenschr 12-15-1988;66(24):1202-1211
Availability: 23 in stock MT-1 is a linear peptide consisting of 13 amino acids with the sequence Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, corresponding to the full -MSH sequence with terminal modifications
Further reading FcRn blockade in CIDP (ADHERE trial) The Lancet Neurology 2024 #PatientEducation #CIDP #Neuromuscular #EvidenceBasedMedicine Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial thelancet.com To view or add a comment, sign in Platelet Hyperreactivity: A Novel Peripheral Biomarker for Preclinical Alzheimers
Peptide therapy when appropriate to stimulate repair and regeneration
